BSG Guideline: Diagnosis and management of patients at risk of gastric adenocarcinoma

British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma

Gastric adenocarcinoma continues to be a frequent cause of death in the world and is the 16th most common cancer in the UK. The most common stages in the progression to gastric adenocarcinoma are gastric atrophy (GA) and gastric intestinal metaplasia (GIM), which are collectively known as chronic atrophic gastritis (CAG). These conditions are principally caused by Helicobacter pylori infection and less commonly by autoimmune gastritis.

The key to having a significant impact on the prognosis of gastric adenocarcinoma and its economic burden is to accurately identify individuals at greatest risk and intervene with recognised efficacious treatments, including endoscopic resection, before cancer is established. The British Society of Gastroenterology (BSG) endoscopy committee agreed to create a guideline to provide statements and recommendations on the prevalence, risks, diagnosis, treatment, surveillance and screening of gastric premalignant and early gastric malignant lesions.

The principal patient group are those found to have GA, GIM, gastric epithelial dysplasia or early gastric adenocarcinoma limited to the mucosal or superficial submucosal layers. The target users include gastroenterologists, GI surgeons, pathologists, endoscopists and general practitioners.

http://dx.doi.org/10.1136/gutjnl-2018-318126

View the full document as a PDF here.

Read More

BSG logo
Clinical Resources Categories
BSG Nurses Association
Inflammatory Bowel Disease
Practice recommendations for midwives caring for women and birthing people living with inflammatory bowel disease
clinical-resource/Practice-recommendations-for-midwives
The following practice recommendations were developed to standardise the midwifery care given to women and birthing people living with IBD during pregnancy.

BSG logo
Guidance
Colorectal
BSG/ACPGBI guidance on the management of colorectal polyps in patients with limited life expectancy
clinical-resource/Management-of-colorectal-polyps-in-patients
This BSG and ACPGBI guidance aims to help clinicians and patients consider these risks to aid decision-making for polypectomy versus a conservative approach.